Article PDF


arterial hypertension, quality of life, gender aspect, SF-36 questionnaire

Abstract views: 118
PDF Downloads: 133

How to Cite



Relevance. Hypertension is one of the most common chronic diseases, for which currently the goal of therapy is not so much recovery as improving circulatory function with a satisfactory quality of life.

Objective: to determine the impact of different degrees of hypertension on quality of life in female and male patients.

Materials and methods. 126 patients with arterial hypertension underwent examination, including 86 women (68%), 40 men (32%) aged 40 to 81 years (mean age 61.9 ± 0.3 years). Arterial hypertension of I degree had 19 people (15.1%), II degree - 65 patients (51.6%), III degree - 42 people (33.3%). The control group consisted of 43 healthy individuals who did not differ from the main group in terms of demographics. Surveys of patients to assess the quality of life conducted with the questionnaire SF-36 (Short Form-36) at each follow-up. Quality of life indicators has value in points.

Results. The analysis of quality of life indicators in the group of healthy people found that the level of quality of life in men is much higher than in healthy women: "physical pain", "role functioning" - P1-P2> 0.5; "Physical functioning" - P1-P2 <0.001; "Physical health" - P1-P2> 0.5, except for the scale "general health" - P1-P2 <0.05 (77.2 ± 3.02 vs. 63.75 ± 2.81).

The comparison of the quality of life of patients with hypertension of I degree and patients with arterial hypertension of III degrees found reliable differences on the scales "Vitality" (P1-P3 <0.001), and "Social functioning" (P1-P3 <0.5). In patients with II and III degrees of arterial hypertension indicators of quality of life were low in themselves and differed on a scale "role functioning" of the questionnaire: "Vital force" (P2-P3> 0,5); "Role functioning" (P2-P3 <0.5); "Mental health" (P2-P3> 0.5).

Patients with hypertension of the I degree in comparison with arterial hypertension of the II degree had reliably higher indicators of quality of life on scales "vital force" (80,0 ± 3,93 points) and "role functioning" (77,1 ± 4,04 points) ), but reduced indicators of "social functioning" and "mental health" (48.7 ± 7.35 and 47.41 ± 2.39 points, respectively).

Patients with hypertension of I degree and III degree showed reliable differences on the scales "vital force" (P1-P3 <0.001) and "social functioning" (P1-P3 <0.5); and patients with hypertension of II and III degrees showed a significant decrease in all indicators of quality of life, especially on the scales "social functioning" and "mental health" (up to 31.5 ± 5.19 and up to 40.31 ± 2.23 points, respectively).

Patients with hypertension of I degree had a decrease in general health (87.1 ± 3.16), physical function (82.6 ± 2.86), and physical pain (87.1 ± 3.16). Patients with II degree of hypertension had a significant reduction in role functioning (32.4 ± 5.19), physical pain, and general health (36.0 ± 6.12 and 42.26 ± 2.68 points, respectively).

Conclusions. Hypertension significantly affects the quality of life. The state of health of patients with hypertension significantly limited their physical activity.
Article PDF


Mancia G., Fagard R., Narkiewicz K., et al. ESH/ESC Guidelines for the management of arterial hypertension // Eur. Heart Jour. 2013 July; 34 (Issue 28): 2159-219.

Hadley S., Petry J.J. Valerian // Am. Fam. Physician. 2003; 67(8): 1755-8.

Asadujjaman M., Mishuk A.U., Hossain M.A., Karmakar UK. Medicinal potential of Passiflora foetida L. plant extracts: biological and pharmacological activities // J. Integr. Med. 2014 01 Mar; 12(2): 121-6. PMID: 24666678. DOI:

Noguchi Shinohara M., Ono K., Hamaguchi T., Iwasa K., Nagai T., Kobayashi Sh., Nakamura H., Yamada M. Pharmacokinetics, Safety and Tolerability of Melissa officinalis Extract which Contained Rosmarinic Acid in Healthy Individuals: A Randomized Controlled Trial // PLoS One. 2015 May 15; 10 (5): e0126422. PMID: 25978046. PMCID: PMC4433273. DOI:

Bernatoniene J., Kopustinskiene D.M., Jakstas V., Majiene D., Baniene R., Kuršvietiene L., Masteikova R., Savickas A., Toleikis A., Trumbeckaite S. The effect of Leonurus cardiaca herb extract and some of its flavonoids on mitochondrial oxidative phosphorylation in the heart // Planta Med. 2014 May; 80 (7): 525-32. PMID: 24841965. DOI:

Treat-Jacobson D., Lindquist R.A., Witt D.R., Kirk L.N., Schorr E.N., Bronas U.G., Davey C.S., Regensteiner J.G. The PADQOL: development and validation of a PAD-specific quality of life questionnaire // Vasc. Med. 2012 Dec; 17(6): 405-15. PMID: 23184901. DOI:

Dalfó Baqué A., Badia Llach X., Roca-Cusachs Coll A., Ruiz I Aristegui, Gamisans M Roset. [Validation of the quality of life questionnaire in arterial hypertension (HQALY) for its use in Spain. Relationship between clinical variables and quality of life. Investigator Group of the HQALY study] // Aten. Primaria. 2000 Jun 30; 26(2): 96-103. [Article in Spanish]. PMID: 10927826. DOI:

Schulz R.B., Rossignoli P., Correr C.J. Fernández-Llimós F., de Toni P.M. [Validation of the short form of the Spanish hypertension quality of life questionnaire (MINICHAL) for Portuguese (Brazil)] // Arq. Bras. Cardiol. 2008 Feb; 90 (2): 127-31. [Article in En, Portuguese] PMID: 18392385. DOI:

Adherencetolong-termtherapies: Evidence for action. Geneva, WHO, 2003. – 198 p.;jsessionid=678C598AB5AACF9A679D72B9BB5F4EF1?sequence=1

Bardage C., Isacson D. Hypertension and health related quality of life: an epidemiological study in Sweden // J. Clin. Epidemiol. 2001 Feb; 54(2): 172-81. PMID: 11166533. DOI:

Barnason S., Zimmermann L., Anderson A., Mohr-Burt S, Nieveen J. Functional status outcomes of patients with a coronary artery by pass graft over time // Heart Lung. 2000 Jan-Feb; 29(1): 33-46. PMID: 10636955. DOI:

Battersby C., Hartley K., Fletcher A., Markowe HJ, Styles W, Sapper H, Bulpitt CJ. Quality of the life in treated hypertension: a cause-control community based study // J. Hum. Hypertens. 1995 Dec01; 9(12): 981-6. PMID: 8746643.

Baroletti S., Dell’Orfano H. Medication adherence in cardiovascular disease // Circulation. 2010 Mar 30; 121(12): 1455-8. PMID: 20351303. DOI:

Deeks A., Lombard C., Michelmore J., Teede H. The efects of gender and ageon health related behaviors // BMC Public Health. 2009; 9: article 213.

Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) // Journal of Hypertension. 2013 Jul; 31(7): 1281-1357. PMID: 23817082. DOI:

Gee M.E., Bienek A., McAlister F.A., Robitaille C., Jofres M., Tremblay M.S., Johansen H., Campbell N.R.C. Factors associated with lack of awareness and uncontrolled high blood pressure among Canadian adults with hypertension // Can. J. Cardiol. 2012 May; 28(3): 375-82. PMID: 22402028. DOI:

Gu Q., Burt V.L., Paulose-Ram R., Dillon C.F. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004 // Am. J. Hypertens. 2008 Jul; 21(7): 789-98. PMID: 18451806. DOI:

Gu Q., Paulose-Ram R., Dillon C., Burt V. Antihypertensive medication seamong US adults with hypertension // Circulation. 2006 Jan 17; 113(2): 213-21. PMID: 16391156. DOI:

Ooi H.H.L., Coleman P.L., Duggan J., O’Meara Y.M. Treatment of hypertension in the elderly // Current Opinion in Nephrology and Hypertension 1997; 6 (5): 504-9.

Ostchega Y., Dillon C.F., Hughes J.P., Carroll M., Yoon S. Trends in hypertension prevalence, awareness, treatment, andcontrol in older U.S. adults:data from the National Health and Nutrition Examination Survey 1988 to 2004 // J. Am. Geriatr. Soc. 2007 Jul; 55(7): 1056-65. PMID: 17608879. DOI:

Roca-Cusachs A., Ametlla J., Calero S. Comas O., Fernández M., Lospaus R., Monmany J., Morera R., Muñoz M., Peris A. [Quality of life in arterial hypertension] // Med. Clin. (Barc). 1992 Apr 4; 98(13): 486-90. [Article in Spanish]. PMID: https://1583946

Roca-Cusachs A., Dalfo A., Badia X., Arístegui I., Roset M. Relation between clini-cal and therapeutic variables and quality of life in hypertension // J. Hypertens. 2001 Oct; 19(10): 1913-9. PMID: 11593114. DOI:

Sang Hui Chu, Ji Won Baek, Eun Sook Kimetal. Gender Differences in Hypertension Control Among Older Korean Adults: Korean Social Life, Health, and Aging Project // J. Prev. Med. Public Health. 2015 Jan; 48(1): 38-47. PMID: 25652709. doi:

Stokes G.S. Management of hypertension in the elderly patients // Clin. Interv. Aging. 2009 Oct 12; 4: 379-89. PMID: 19851513. doi:

Zamorano J., Rodriguez P., Cosín J. Hernandiz A., Gutierrez-Chico J.L., de Isla L Pérez, Arístegui R., Masramon X., CORONARIA Study Group. Amlodipine reduces predicted risk of coronary heart disease in high-risk patients with hypertension in Spain (The CORONARIA Study) // J. Int. Med. Res. 2008 Nov-Dec; 36 (6): 1399-417. PMID: 19094452. DOI:

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.